Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro

Molly Kulesz-Martin, Leslie Blumenson, Barbara Lisafeld

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.

Original languageEnglish (US)
Pages (from-to)1425-1429
Number of pages5
JournalCarcinogenesis
Volume7
Issue number9
DOIs
StatePublished - Sep 1986
Externally publishedYes

Fingerprint

Carcinogens
Tretinoin
Mouse
Enhancement
Acids
Cell
Assays
Cells
Methylnitronitrosoguanidine
9,10-Dimethyl-1,2-benzanthracene
Cloning
Experiments
Retinoids
Chemoprevention
Dose
Therapeutics
Acetone
Fold
Organism Cloning
Experiment

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Behavioral Neuroscience
  • Cancer Research

Cite this

Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro. / Kulesz-Martin, Molly; Blumenson, Leslie; Lisafeld, Barbara.

In: Carcinogenesis, Vol. 7, No. 9, 09.1986, p. 1425-1429.

Research output: Contribution to journalArticle

Kulesz-Martin, Molly ; Blumenson, Leslie ; Lisafeld, Barbara. / Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro. In: Carcinogenesis. 1986 ; Vol. 7, No. 9. pp. 1425-1429.
@article{637ace54fae34f29811b3e522b41b0e2,
title = "Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro",
abstract = "Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.",
author = "Molly Kulesz-Martin and Leslie Blumenson and Barbara Lisafeld",
year = "1986",
month = "9",
doi = "10.1093/carcin/7.9.1425",
language = "English (US)",
volume = "7",
pages = "1425--1429",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro

AU - Kulesz-Martin, Molly

AU - Blumenson, Leslie

AU - Lisafeld, Barbara

PY - 1986/9

Y1 - 1986/9

N2 - Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.

AB - Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.

UR - http://www.scopus.com/inward/record.url?scp=0022779695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022779695&partnerID=8YFLogxK

U2 - 10.1093/carcin/7.9.1425

DO - 10.1093/carcin/7.9.1425

M3 - Article

VL - 7

SP - 1425

EP - 1429

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -